Nurtec (BHV-0223)
Nurtec (formerly BHV-0223) is a new formulation of riluzole that is placed under the tongue and dissolves in the mouth. The therapy is being developed by Biohaven Pharmaceuticals for treating amyotrophic lateral sclerosis (ALS). How Nurtec works Riluzole is a glutamate-modulating agent. Its exact mechanism of…